Anavex Life Sciences Statistics
Total Valuation
AVXL has a market cap or net worth of $376.25 million. The enterprise value is $244.50 million.
Important Dates
The last earnings date was Monday, February 9, 2026, before market open.
| Earnings Date | Feb 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AVXL has 92.67 million shares outstanding. The number of shares has increased by 2.61% in one year.
| Current Share Class | 92.67M |
| Shares Outstanding | 92.67M |
| Shares Change (YoY) | +2.61% |
| Shares Change (QoQ) | +3.65% |
| Owned by Insiders (%) | 3.12% |
| Owned by Institutions (%) | 41.15% |
| Float | 89.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.97 |
| P/TBV Ratio | 2.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.87
| Current Ratio | 20.87 |
| Quick Ratio | 20.81 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -33.63% and return on invested capital (ROIC) is -23.33%.
| Return on Equity (ROE) | -33.63% |
| Return on Assets (ROA) | -21.56% |
| Return on Invested Capital (ROIC) | -23.33% |
| Return on Capital Employed (ROCE) | -35.01% |
| Weighted Average Cost of Capital (WACC) | 10.02% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.17M |
| Employee Count | 34 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVXL has paid $18,000 in taxes.
| Income Tax | 18,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.74% in the last 52 weeks. The beta is 1.05, so AVXL's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | -58.74% |
| 50-Day Moving Average | 4.51 |
| 200-Day Moving Average | 7.19 |
| Relative Strength Index (RSI) | 37.24 |
| Average Volume (20 Days) | 1,140,553 |
Short Selling Information
The latest short interest is 20.37 million, so 21.98% of the outstanding shares have been sold short.
| Short Interest | 20.37M |
| Short Previous Month | 20.53M |
| Short % of Shares Out | 21.98% |
| Short % of Float | 22.68% |
| Short Ratio (days to cover) | 15.94 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -44.33M |
| Pretax Income | -39.93M |
| Net Income | -39.95M |
| EBITDA | n/a |
| EBIT | -44.33M |
| Earnings Per Share (EPS) | -$0.46 |
Full Income Statement Balance Sheet
The company has $131.75 million in cash and n/a in debt, with a net cash position of $131.75 million or $1.42 per share.
| Cash & Cash Equivalents | 131.75M |
| Total Debt | n/a |
| Net Cash | 131.75M |
| Net Cash Per Share | $1.42 |
| Equity (Book Value) | 126.62M |
| Book Value Per Share | 1.37 |
| Working Capital | 126.62M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -34.08M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -34.08M |
| FCF Per Share | -$0.37 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVXL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.61% |
| Shareholder Yield | -2.61% |
| Earnings Yield | -10.62% |
| FCF Yield | -9.06% |
Analyst Forecast
The average price target for AVXL is $22.00, which is 441.87% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $22.00 |
| Price Target Difference | 441.87% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 7, 2015. It was a reverse split with a ratio of 1:4.
| Last Split Date | Oct 7, 2015 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |